Industry News
Annual CEO industry survey to check the 'pulse' of the Australian industry
AusBiotech calls on industry leaders (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2014 in order to contribute to the annual snapshot and build the advocacy platform for the year to come. [ + ]
Transforming catheter placement
A new tool that guides catheter placement is being taken up by Australian hospitals. [ + ]
Thousand-dollar genome a reality
The dream of sequencing an entire human genome for $1000 has become a reality. [ + ]
Academy of Science awards scientific excellence
The 2014 winners of the Australian Academy of Science's prestigious annual awards for scientific excellence have been announced. [ + ]
Cochlear facing $150m penalty from patent case
A US jury has found Cochlear (ASX:COH) liable of patent infringement and awarded damages of US$131.2m, but the company has vowed to appeal. [ + ]
iSonea products recognised at CES
iSonea (ASX:ISN) has picked up a Tech Podcast Network award for its asthma symptom monitoring tools AirSonea and AsthmaSense Prime. [ + ]
Immuron to raise $9.6m in rights issue
Immuron (ASX:IMC) has commenced a $9.6m capital raising, for purposes including raising funds for upcoming phase IIb trial of IMM-124E in NASH. [ + ]
ANSTO celebrates the International Year of Crystallography
The study of crystallography - the only technique for examining the arrangement and structure of matter or materials at the atomic or molecular level - is around 100 years old. In light of this, the United Nations Educational, Scientific and Cultural Organisation (UNESCO) has declared 2014 the International Year of Crystallography (IYCr2014). [ + ]
Review resumes on employee share schemes for start-ups
The federal government has resumed a review on Employee Share Schemes that had paused pre-election when the government entered caretaker mode. Submissions that were lodged previously with the government will be considered as part of this consultation process and new submissions will be accepted now. [ + ]
Hookworm genome sequenced
The genome of the hookworm, the most common soil-transmitted parasitic worm, has been sequenced. [ + ]
Regeneus lines up manufacturer for US CryoShot trial
Global stem cell manufacturer Lonza has agreed to produce the stocks of Regeneus' (ASX:RGS) cell therapy CryoShot Canine for an upcoming US marketing study. [ + ]
Old trees continue to grow and store more carbon
An international study has found that trees do not slow in their growth rate as they get older and larger. In some cases, large trees appear to be adding the carbon mass equivalent of an entire mid-sized tree each year and are thus better at absorbing carbon from the atmosphere than previously thought. [ + ]
University of Melbourne and Sanofi Pasteur to develop human vaccines
Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university's commercial engagement services company. [ + ]
Bioluminescence alliance receives ARC Linkage Grant
A team of world leaders in the field of biomolecular interaction, relating to basic biomedical research and the discovery of new pharmaceuticals, has been the recipient of an Australian Research Council (ARC) Linkage Grant. [ + ]
Qiagen and Exosome Diagnostics to develop diagnostics for genetic biomarkers in cancers
Qiagen and Exosome Diagnostics have expanded their strategic partnership to develop non-invasive, in-vitro molecular diagnostics for detecting and monitoring actionable genetic mutations in lung-cancer patients. [ + ]
